Surviving Lymphoma: Secondary Cancers

Secondary cancers are cancers that develop as a result of chemotherapy and/or radiotherapy. These cancers are usually unrelated to the first disease a patient suffered from. Rather, they are a long-term side effect of the treatment used to combat the original cancer.

These side-effects can occur months or years after a patient enters remission. The use of strong chemotherapy agents like etoposide, high doses of radiation, or combination chemo and radiation therapy all increase a patient's risk of developing a secondary cancer.

Due to this possibility, cancer survivors are monitored closely by their doctors. That way, if a secondary cancer does arise, it will be caught early when it is treatable.

Hodgkin's Lymphoma

For Hodkgin's Lymphoma, the most common secondary cancers are:

  • Stomach cancer
  • Lung cancer
  • Colorectal cancer
  • Thyroid cancer
  • Breast cancer
  • Bone cancer
  • Leukemia
  • Non-Hodgkin Lymphoma

The chance for developing a secondary cancer after 20 years of remission is 10%. This risk increases to 26% after 30 years. Patients who were younger than 21 years of age during their treatment have a higher incidence of secondary cancers, and that risk increases if both chemotherapy and radiation were used.

Non-Hodgkin's Lymphoma (NHL)

The most common secondary cancers after treatment for Non-Hodgkin's Lymphomas are:

  • Leukemia
  • Other Non-Hodgkin's Lymphomas

The incidence rates for secondary cancers are usually lower when compared to Hodgkin's patients. However, these statistics change based on the type of NHL and the treatment used.

Photo: Pexels

lymphoma roundup

More Articles

More Articles

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

In general, a diagnosis of T-cell lymphoma denotes a poorer prognosis than a diagnosis of B-cell lymphoma. One of...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...